Association Between Serum Galectin‐3 and Parkinson's Disease: A Two‐Sample Mendelian Randomization Study.

Autor: Pan, Rui¹ (AUTHOR), Li, Wei² (AUTHOR), Wang, Jinyuan³ (AUTHOR), Xie, Jiarong¹ (AUTHOR), Weng, Xiucan¹ (AUTHOR), Yang, Ying¹ (AUTHOR), Shi, Xiaolei^4,5,6,7,8 (AUTHOR) shixl@gzhmu.edu.cn

Publikováno v: Brain & Behavior. Oct2024, Vol. 14 Issue 10, p1-8. 8p.

Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients.

Autor: Andreassen CN; Department of Experimental Clinical Oncology, Aarhus University Hospital, Denmark. Electronic address: nicolaj@oncology.au.dk., Rosenstein BS; Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, USA., Kerns SL; Department of Radiation Oncology, University of Rochester Medical Center, USA; Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, USA., Ostrer H; Departments of Pathology and Pediatrics, Albert Einstein College of Medicine, New York, USA., De Ruysscher D; Department of Radiotherapy (Maastro Clinic), Maastricht University Medical Center, The Netherlands., Cesaretti JA; Southpoint Cancer Center, Jacksonville, USA., Barnett GC; Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, UK; Centre for Cancer Genetic Epidemiology, Strangeways Research Laboratory, University of Cambridge, UK., Dunning AM; Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, UK; Centre for Cancer Genetic Epidemiology, Strangeways Research Laboratory, University of Cambridge, UK., Dorling L; Centre for Cancer Genetic Epidemiology, Strangeways Research Laboratory, University of Cambridge, UK., West CML; Institute of Cancer Sciences, University of Manchester, The Christie NHS Foundation Trust, UK., Burnet NG; Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, UK., Elliott R; Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, UK., Coles C; Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, UK., Hall E; Clinical Trials & Statistics Unit (ICR-CTSU), The Institute of Cancer Research, London, UK., Fachal L; Fundacion Publica Galega de Medicina Xenomica-SERGAS, Grupo de Medicina Xenomica-USC, IDIS, CIBERER, Santiago de Compostela, Spain., Vega A; Fundacion Publica Galega de Medicina Xenomica-SERGAS, Grupo de Medicina Xenomica-USC, IDIS, CIBERER, Santiago de Compostela, Spain., Gómez-Caamaño A; Department of Radiation Oncology, Complexo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain., Talbot CJ; Department of Genetics, University of Leicester, UK., Symonds RP; Department of Cancer Studies, University of Leicester, UK., De Ruyck K; Department of Basic Medical Sciences, Ghent University, Belgium., Thierens H; Department of Basic Medical Sciences, Ghent University, Belgium., Ost P; Department of Radiotherapy, Ghent University Hospital, Belgium., Chang-Claude J; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; University Cancer Center Hamburg, University (UCCH), University Medical Center Hamburg-Eppendorf, Germany., Seibold P; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Popanda O; Division of Epigenomics and Cancer Risk Factors, German Cancer Research Center (DKFZ), Heidelberg, Germany., Overgaard M; Department of Experimental Clinical Oncology, Aarhus University Hospital, Denmark., Dearnaley D; The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK., Sydes MR; MRC Clinical Trials Unit at UCL, London, UK., Azria D; Department of Radiation Oncology and Medical Physics, Institut regional du Cancer Montpellier, France., Koch CA; Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada., Parliament M; Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Canada., Blackshaw M; Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Canada., Sia M; Department of Radiation Oncology, British Columbia Cancer Agency Abbotsford Clinic, Canada., Fuentes-Raspall MJ; Department of Radiation Oncology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Ramon Y Cajal T; Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Barnadas A; Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Vesprini D; Department of Radiation Oncology, Sunnybrook Health Sciences Centre, Toronto, Canada., Gutiérrez-Enríquez S; Oncogenetics Group, Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Spain., Mollà M; Department of Radiation Oncology, Vall d'Hebron University Hospital, Barcelona, Spain., Díez O; Oncogenetics Group, Vall d'Hebron Institute of Oncology (VHIO), Area of Clinical and Molecular Genetics, Vall d'Hebron University Hospital, Barcelona, Spain., Yarnold JR; The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK., Overgaard J; Department of Experimental Clinical Oncology, Aarhus University Hospital, Denmark., Bentzen SM; Greenebaum Cancer Center and Department of Epidemiology & Public Health, University of Maryland School of Medicine, Baltimore, USA., Alsner J; Department of Experimental Clinical Oncology, Aarhus University Hospital, Denmark.

Publikováno v: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2016 Dec; Vol. 121 (3), pp. 431-439. Date of Electronic Publication: 2016 Jul 18.

Integrative Single‐Cell Transcriptomics and Epigenomics Mapping of the Fetal Retina Developmental Dynamics.

Autor: Li, Ruonan^1,2,3,4 (AUTHOR), Liu, Jiangyi^1,2,3,4 (AUTHOR), Yi, Ping⁵ (AUTHOR), Yang, Xianli⁵ (AUTHOR), Chen, Jun⁶ (AUTHOR), Zhao, Chenyang^1,2,3,4 (AUTHOR), Liao, Xingyun^1,2,7 (AUTHOR), Wang, Xiaotang^1,2,3,4 (AUTHOR), Xu, Zongren^1,2 (AUTHOR), Lu, Huiping^1,2,3,4 (AUTHOR), Li, Hongshun^1,2,3,4 (AUTHOR), Zhang, Zhi^1,2,3,4 (AUTHOR), Liu, Xianyang^1,2,3,4 (AUTHOR), Xiang, Junjie^1,2,3,4 (AUTHOR), Hu, Ke^1,2,3,4 (AUTHOR), Qi, Hongbo^6,8 (AUTHOR), Yu, Jia^9,10 (AUTHOR), Yang, Peizeng^1,2,3,4 (AUTHOR), Hou, Shengping^1,2,3,4,11 (AUTHOR) sphou828@163.com

Publikováno v: Advanced Science. 6/2/2023, Vol. 10 Issue 16, p1-17. 17p.

Genetically Proxied Antidiabetic Drug Target and Primary Open‐Angle Glaucoma: A Mendelian Randomization Study.

Autor: Tang, Kefu, Wang, Wenqiu, Chang, Weiteng, Wu, Xi

Publikováno v: Health Science Reports; Oct2024, Vol. 7 Issue 10, p1-9, 9p

Equity Challenges in Canada's Old Age Security Pension: Income Eligibility and Cost of Living Considerations.

Autor: Hajizadeh, Mohammad, Ferro, Thiago, Grignon, Michel

Publikováno v: Canadian Public Policy; Jun2024, Vol. 50 Issue 2, p232-242, 11p